Elevance Health (ELV) Financial Analysis & Valuation | Quarter Chart
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, phar... more
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and com... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $89.12B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Plans |
| Country | US | CEO | Gail Koziara Boudreaux |
| IPO Date | 2001-10-30 | CAGR | 11.3% |
| Employees | 96,615 | Website | www.elevancehealth.com |
| Div. Yield | 1.22% | Payout Ratio | 30% |
| Buy Back Yield | 2.23% | Total Yield | 3.45% |
ELV chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $108.88B | P/E | 13.98 | Forward P/E | 13.91 | PEG | -1.4 |
| P/S | 0.57 | P/B | 2.68 | P/CF | 16.33 | P/FCF | 19.29 |
| Sales | $201.11B | Sales 1Y | 6.27% | Sales 3Y | 21.36% | Sales 5Y | 55.64% |
| EPS | $29.39 | EPS 1Y | -4.26% | EPS 3Y | -14.45% | EPS 5Y | 32.2% |
| Sales QoQ | 0.58% | EPS QoQ | -16.12% | Sales QoQ Avg | 0.36% | EPS QoQ Avg | 30.78% |
| Gross Margin | 38.95% | Operating Margin | 3.51% | Profit Margin | 2.47% | ROCE | 8.59% |
| ROA | 4% | ROE | 11% | Altman Z Score | 2.63 | Piotroski Score | 8 |
| Current Ratio | 1.52 | Quick Ratio | 1.52 | Cash Ratio | 0.23 | Op. CF Ratio | 0.04 |
| Debt/Equity | 0.69 | Debt/Assets | 0.25 | Lt Debt/Equity | 0.68 | Lt Debt/Cap. | 0.41 |
| Intrst Cov. | 6.25 | Inventory Turnover | — | Asset Turnover | 1.59 | Receivables Turnover | 8.6 |
| Enterprise Value | $108.88B | P/E Ratio | 13.98 |
| Forward P/E | 13.91 | PEG Ratio | -1.4 |
| P/S Ratio | 0.57 | P/B Ratio | 2.68 |
| P/CF Ratio | 16.33 | P/FCF Ratio | 19.29 |
| EPS | $29.39 | EPS Growth 1Y | -4.26% |
| EPS Growth 3Y | -14.45% | EPS Growth 5Y | 32.2% |
| Revenue Growth 1Y | 6.27% | Gross Margin | 38.95% |
| Operating Margin | 3.51% | Profit Margin | 2.47% |
| ROE | 11% | ROA | 4% |
| ROCE | 8.59% | Current Ratio | 1.52 |
| Quick Ratio | 1.52 | Cash Ratio | 0.23 |
| Debt/Equity | 0.69 | Interest Coverage | 6.25 |
| Altman Z Score | 2.63 | Piotroski Score | 8 |
Elevance Health (ELV) valuation & financials
Elevance Health (ELV) has a market capitalization of $89.12B and trades at a price-to-earnings ratio of 14.0. It operates in the Healthcare sector (Medical - Healthcare Plans).
Elevance Health's revenue grew +6.3% over the last year.
Elevance Health's next earnings report is scheduled for October 21, 2026 before market open (provider scheduled date); analysts estimate EPS of $4.66. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)